We are live on ! Find out more
MCAV

Meritech Capital Associates V Portfolio holdings

AUM $141M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+15.44%
3 Year Est. Return
+37.35%
5 Year Est. Return
+8.8%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$7.05M
Cap. Flow
-$9.61M
Cap. Flow %
-3.22%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$9.61M

Sector Composition

Rank Sector Weight
1 Communication Services 63.86%
2 Technology 36.14%
3 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RBLX icon
1
Roblox
RBLX
$25.7B
$191M 63.86%
4,310,520
– –
DDOG icon
2
Datadog
DDOG
$81.6B
$108M 36.14%
938,437
– –
TXG icon
3
10x Genomics
TXG
$5.79B
– –
-494,236
Closed -$9.61M

Similar funds

CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
SFS
Sunrise Financial Services Burien, Washington $141M AUM
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return
OFA
Orographic Financial Advisors Avon, Colorado $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
WA
Watchtower Advisors Old Greenwich, Connecticut $141M AUM 47.85% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return

Meritech Capital Associates V's Q3 2024 Portfolio in Review

As of Q3 2024, Meritech Capital Associates V held 3 positions worth $299M, up 2.4% from $292M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meritech Capital Associates V withdrew a net $9.61M in Q3 2024, closing 1 position. Its most notable exit was 10x Genomics, an estimated $9.61M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 64% of assets, up from 55% a quarter earlier, followed by Technology and Healthcare.

  • Meritech Capital Associates V fully exited 10x Genomics in Q3 2024, selling an estimated $9.61M.
  • Meritech Capital Associates V's ten largest holdings make up 100% of its $299M portfolio in Q3 2024.
  • Meritech Capital Associates V opened 0 new positions and closed 1 in Q3 2024.
  • Meritech Capital Associates V's portfolio value rose 2.4% quarter-over-quarter to $299M.

Based on Meritech Capital Associates V's 13F filing for Q3 2024, filed 14 Nov 2024.